Paul Greliak
Researcher
Faculty of Medicine
National Heart Lung Institute
United Kingdom
Biography
I am currently working as the REACT Trial monitor, based at the Cancer Research UK Imperial Centre: Clinical Trials Section. REACT (Randomised EuropeAn Celecoxib Trial) is a phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients. Previous I worked as a clinical trials manager at the Cancer Screening and Prevention Research Group (CSPRG), Imperial College London. I have 10 years of experience working in the field of cancer, having also worked at the Thames Cancer Registry, Kings College London.
Research Interest
Cancer
